Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: Lückel, Christina
Eará dahkkit: Huber, Magdalena (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Materiálatiipa: Dissertation
Giella:eaŋgalasgiella
Almmustuhtton: Philipps-Universität Marburg 2018
Fáttát:
multiple sclerosis
IL-17
Multiple Sklerose
ROS
Tc17 cells
Dimethyl fumarate
Tc17 Zellen
Dimethylfumarat
Medizin
Medical sciences Medicine
Liŋkkat:PDF-ollesdeaksta
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

PDF-ollesdeaksta

oažžasuvvan:
Hildobáiki: urn:nbn:de:hebis:04-z2018-03301
Almmustuhttinbeaivi: 2019-02-28
Datum der Annahme: 2018-08-15
Downloads: 45 (2024), 86 (2023), 69 (2022), 72 (2021), 76 (2020), 69 (2019)
Lizenz: https://creativecommons.org/licenses/by-nc-sa/4.0
Liŋka materiálii: https://archiv.ub.uni-marburg.de/diss/z2018/0330
https://doi.org/10.17192/z2018.0330

Geahča maid